These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 4340591)

  • 21. [Therapy of gout attacks with synthetic delayed-action ACTH].
    Muzzolini M; Rosetto G; Compagnoni A
    Policlinico Med; 1970; 77(6):322-32. PubMed ID: 4331713
    [No Abstract]   [Full Text] [Related]  

  • 22. [Use of Cortrosyn Depot in dermatology].
    Aussems J
    Brux Med; 1976 Jan; 56(1):15-20. PubMed ID: 175889
    [No Abstract]   [Full Text] [Related]  

  • 23. The therapeutic uses of long acting ACTH.
    Weaver JA
    Scott Med J; 1978 Apr; 23(2):153-60. PubMed ID: 205942
    [No Abstract]   [Full Text] [Related]  

  • 24. [Current status of treatment with a synthetic corticotropic peptide, tetracosactide-retard].
    Deguillaume R
    Presse Med (1893); 1971 Jan; 79(6):233-5. PubMed ID: 4323028
    [No Abstract]   [Full Text] [Related]  

  • 25. [Therapy with ACTH (corticotropin)--unjustly neglected in Germany].
    Gross F
    Internist (Berl); 1974 Jan; 15(1):52-4. PubMed ID: 4360019
    [No Abstract]   [Full Text] [Related]  

  • 26. Comparison of the hypothalamic-pituitary-adrenal axis susceptibility upon single-dose i.m. depot versus long-acting i.v. triamcinolone acetonide therapy: a direct pharmacokinetic correlation.
    Abraham G; Demiraj F; Ungemach FR
    J Endocrinol; 2006 Nov; 191(2):491-6. PubMed ID: 17088419
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Therapeutical possibilities of a synthetic delayed action tetracosapeptide (ACTH-like) in dermatology].
    Sartoris S; Pippione M; Strani GF
    G Ital Dermatol Minerva Dermatol; 1969 Jun; 44(6):301-10. PubMed ID: 5409070
    [No Abstract]   [Full Text] [Related]  

  • 28. [Long-term corticoid therapy in dermatology].
    Weitgasser H
    Arch Dermatol Forsch; 1972; 244():403-5. PubMed ID: 4648732
    [No Abstract]   [Full Text] [Related]  

  • 29. Elimination of severe height growth suppression caused by treatment with betamethasone after switching to ACTH-depot in chronic bronchial asthma.
    Moulaert AJ; Van Gemund JJ
    Helv Paediatr Acta; 1972 Apr; 21(1):55-62. PubMed ID: 4336638
    [No Abstract]   [Full Text] [Related]  

  • 30. Microphallus pygmaeus: effect of long-acting ACTH preparation on establishment and retention in alimentary canal of the mouse.
    Mills AR; Brain PF; James BL
    Exp Parasitol; 1973 Oct; 34(2):251-6. PubMed ID: 4355414
    [No Abstract]   [Full Text] [Related]  

  • 31. [Clinical and pharmacologic studies of synthetic ACTH].
    Bíró L; Iván E; Sándor P; Perényi T
    Orv Hetil; 1971 Jun; 112(23):1327-9. PubMed ID: 4327819
    [No Abstract]   [Full Text] [Related]  

  • 32. [Remarks on the priority of Hungarian ACTH production and the possible stabilizing effect of depot preparations].
    Fekete G; Hajós M
    Orv Hetil; 1970 Nov; 111(45):2691-2. PubMed ID: 4321388
    [No Abstract]   [Full Text] [Related]  

  • 33. [MSH-like effect of synthetic corticotropins in man].
    Santoianni P; Berruti G
    G Ital Dermatol Minerva Dermatol; 1971 Aug; 46(8):346-9. PubMed ID: 4329818
    [No Abstract]   [Full Text] [Related]  

  • 34. [Letter: Synthetic ACTH in rheumatic diseases. Münch. med. Wschr. 117 (1975) 1849].
    Schilling F
    MMW Munch Med Wochenschr; 1976 Apr; 118(17):549. PubMed ID: 178996
    [No Abstract]   [Full Text] [Related]  

  • 35. Synacthen depot.
    Drug Ther Bull; 1969 Jan; 7(1):4. PubMed ID: 4302906
    [No Abstract]   [Full Text] [Related]  

  • 36. Treatment of bronchial asthma with synthetic long-term corticotrophin.
    Anderson E; Lorenzen J
    Scand J Respir Dis Suppl; 1970; 72():127. PubMed ID: 4320311
    [No Abstract]   [Full Text] [Related]  

  • 37. [Studies on the corticotropic effectiveness of a synthetic, ACTH-like pentacosapeptide in man].
    Pointner H; Geyer G; Stern I
    Wien Klin Wochenschr; 1968 Sep; 80(36):668-71. PubMed ID: 4300460
    [No Abstract]   [Full Text] [Related]  

  • 38. [Studies on the behavior of serum proteins after the use of alteratives & ACTH & cortisone treatment in skin diseases].
    WERNSDORFER R
    Arch Klin Exp Dermatol; 1957; 206():617-23. PubMed ID: 13522094
    [No Abstract]   [Full Text] [Related]  

  • 39. [Effect of (L-Phe7) and (D-Phe7) ACTH 4-7 and an ACTH 4-7 analog with prolonged action on acetylcholinesterase activity in the rat brain].
    Aleksidze NG; Balavadze MV; Ponomareva-Stepnaia MA; Nezavibat'ko VN; Alferova LIu
    Biull Eksp Biol Med; 1983 Jul; 96(7):24-6. PubMed ID: 6307421
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Melanoderma as a side effect of cortisone depot therapy].
    Rainova R; Kaloianov K
    Vutr Boles; 1974; 13(2):120-2. PubMed ID: 4370659
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.